Your browser doesn't support javascript.
loading
Optimizing a Multi-Component Intranasal Entamoeba Histolytica Vaccine Formulation Using a Design of Experiments Strategy.
Abhyankar, Mayuresh M; Orr, Mark T; Kinsey, Robert; Sivananthan, Sandra; Nafziger, Andrew J; Oakland, David N; Young, Mary K; Farr, Laura; Uddin, Md Jashim; Leslie, Jhansi L; Burgess, Stacey L; Liang, Hong; De Lima, Ines; Larson, Elise; Guderian, Jeffrey A; Lin, Susan; Kahn, Aaron; Ghosh, Prakash; Reed, Sierra; Tomai, Mark A; Pedersen, Karl; Petri, William A; Fox, Christopher B.
Afiliação
  • Abhyankar MM; Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia Health System, Charlottesville, VA, United States.
  • Orr MT; Infectious Disease Research Institute (IDRI), Seattle, WA, United States.
  • Kinsey R; Department of Global Health, University of Washington, Seattle, WA, United States.
  • Sivananthan S; Infectious Disease Research Institute (IDRI), Seattle, WA, United States.
  • Nafziger AJ; Infectious Disease Research Institute (IDRI), Seattle, WA, United States.
  • Oakland DN; Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia Health System, Charlottesville, VA, United States.
  • Young MK; Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia Health System, Charlottesville, VA, United States.
  • Farr L; Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia Health System, Charlottesville, VA, United States.
  • Uddin MJ; Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia Health System, Charlottesville, VA, United States.
  • Leslie JL; Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia Health System, Charlottesville, VA, United States.
  • Burgess SL; Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia Health System, Charlottesville, VA, United States.
  • Liang H; Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia Health System, Charlottesville, VA, United States.
  • De Lima I; Infectious Disease Research Institute (IDRI), Seattle, WA, United States.
  • Larson E; Infectious Disease Research Institute (IDRI), Seattle, WA, United States.
  • Guderian JA; Infectious Disease Research Institute (IDRI), Seattle, WA, United States.
  • Lin S; Infectious Disease Research Institute (IDRI), Seattle, WA, United States.
  • Kahn A; Infectious Disease Research Institute (IDRI), Seattle, WA, United States.
  • Ghosh P; Infectious Disease Research Institute (IDRI), Seattle, WA, United States.
  • Reed S; Infectious Disease Research Institute (IDRI), Seattle, WA, United States.
  • Tomai MA; Infectious Disease Research Institute (IDRI), Seattle, WA, United States.
  • Pedersen K; 3M Corporate Research Materials Laboratory, 3M Center, St Paul, MN, United States.
  • Petri WA; TECHLAB, Inc., Blacksburg, VA, United States.
  • Fox CB; Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia Health System, Charlottesville, VA, United States.
Front Immunol ; 12: 683157, 2021.
Article em En | MEDLINE | ID: mdl-34248966
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Protozoárias / Entamoeba histolytica / Entamebíase / Antígenos de Protozoários Tipo de estudo: Observational_studies / Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Front Immunol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Suíça
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Protozoárias / Entamoeba histolytica / Entamebíase / Antígenos de Protozoários Tipo de estudo: Observational_studies / Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Front Immunol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Suíça